Watch The Hot Spots For Pharma Self-Regulation

Law360, New York (July 12, 2013, 1:06 PM EDT) -- As the global trend toward legislatively mandated transparency in the relationships between life sciences companies and health care professionals accelerates, the pharmaceutical industry is actively pursuing a different approach — self regulation. Supporters of transparency legislation argue that only governmentally imposed disclosure will reduce the cost of drugs and the prevalence of corruption.

Conversely, advocates of industry self-regulation emphasize that only their approach can lead to global uniformity and a much more manageable, understandable and cost-effective path to transparency. As the debate between supporters of government...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.